نتایج جستجو برای: eluting stents

تعداد نتایج: 19304  

Journal: :International journal of cardiology 2005
Barend L van der Hoeven Nuno M M Pires Hazem M Warda Pranobe V Oemrawsingh Bart J M van Vlijmen Paul H A Quax Martin J Schalij Ernst E van der Wall J Wouter Jukema

In-stent restenosis is the major drawback of percutaneous coronary interventions, occurring in 10-40% of the patients. Recently, new stents have emerged which are loaded with anti-inflammatory, anti-migratory, anti-proliferative or pro-healing drugs. These drugs are supposed to inhibit inflammation and neointimal growth and subsequently in-stent restenosis. In this review article the results of...

Journal: :The American journal of cardiology 2009
Christoph A Nienaber Ibrahim Akin Steffen Schneider Jochen Senges Thomas Fetsch Ulrich Tebbe Stefan N Willich Jürgen Stumpf Georg V Sabin Sigmund Silber Gert Richardt Karl-Heinz Kuck

The prospective multicenter German Drug-Eluting Stent (DES.DE) registry is an observational study to analyze and evaluate the therapeutic principle of the differential drug-eluting stents (sirolimus- and paclitaxel-eluting stents) and bare metal stents under real world conditions in the context of the German healthcare system. The baseline clinical and angiographic characteristics and follow-up...

Journal: :Sao Paulo medical journal = Revista paulista de medicina 2007
Hernani Pinto de Lemos Alvaro Nagib Atallah

CONTEXT AND OBJECTIVE The safety and efficacy of drug-eluting stents reduce the need for surgical revascularization. The objective of the present study was to investigate whether paclitaxel or rapamycin-eluting stent are effective in avoiding the need for coronary-artery bypass grafting. METHODS This was a systematic review of the literature using the methodology of the Cochrane Collaboration...

2010
Michael Maeng Niels Ramsing Holm Anne Kaltoft Lisette Okkels Jensen Hans-Henrik Tilsted Leif Thuesen Jens Flensted Lassen

The safety and efficacy of coronary stents, utilized for treatment of ischemic heart disease, have been evaluated extensively. In comparison with bare-metal stents, first-generation drug-eluting stents more than halved the need for target lesion revascularization, but long-term safety has been questioned, as the first-generation drug-eluting stents seem to be associated with a small, but increa...

Journal: :Revista espanola de cardiologia 2013
Takashi Muramatsu Yoshinobu Onuma Yao-Jun Zhang Christos V Bourantas Alexander Kharlamov Roberto Diletti Vasim Farooq Bill D Gogas Scot Garg Hector M García-García Yukio Ozaki Patrick W Serruys

First generation drug-eluting stents have considerably reduced in-stent restenosis and broadened the applications of percutaneous coronary interventions for the treatment of coronary artery disease. The polymer is an integral part of drug-eluting stents in that, it controls the release of an antiproliferative drug. The main safety concern of first generation drug-eluting stents with permanent p...

Journal: :JAMA 2012
Lorenz Räber Henning Kelbæk Miodrag Ostojic Andreas Baumbach Dik Heg David Tüller Clemens von Birgelen Marco Roffi Aris Moschovitis Ahmed A Khattab Peter Wenaweser Robert Bonvini Giovanni Pedrazzini Ran Kornowski Klaus Weber Sven Trelle Thomas F Lüscher Masanori Taniwaki Christian M Matter Bernhard Meier Peter Jüni Stephan Windecker

CONTEXT The efficacy and safety of drug-eluting stents compared with bare-metal stents remains controversial in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). OBJECTIVE To compare stents eluting biolimus from a biodegradable polymer with bare-metal stents in primary PCI. DESIGN, SETTING, AND PATIENTS A prospectiv...

2012
Ashraf Alazzoni Ayman Al-Saleh Sanjit S. Jolly

Background. Individual randomized trials have suggested that everolimus-eluting stents may have improved clinical outcomes compared to paclitaxel-eluting stents, but individual trials are underpowered to examine outcomes such as mortality and very late stent thrombosis. Methods. Medline, Cochrane, and conference proceedings were searched for randomized trials comparing everolimus versus paclita...

Ali Eshraghi, Amir Hossein Khosh Nasab Mahmoud Mohammadzadeh Shabestri Majid Jalalyazdi,

Introduction: This study aimed to evaluate the effects of four-time inflation of the stent balloon at nominal pressure on optimal stent expansion in resistant lesions. Materials and Methods: This interventional study was conducted on 39 patients with coronary artery lesions, in whom Zotarolimus-eluting stents (N=20), Paclitaxel-eluting stents (N=11) and other stents (N=8) were deployed four tim...

Journal: :Revista espanola de cardiologia 2014
Petri O Tuomainen Jussi Sia Wail Nammas Matti Niemelä Juhani K E Airaksinen Fausto Biancari Pasi P Karjalainen

INTRODUCTION AND OBJECTIVES We performed a pooled analysis based on patient-level data from the TITAX-AMI and BASE-ACS trials to evaluate the outcome of titanium-nitride-oxide-coated bioactive stents vs drug-eluting stents in patients with ST-segment elevation myocardial infarction at 2-year follow-up. METHODS The TITAX-AMI trial compared bioactive stents with paclitaxel-eluting stents in 425...

Journal: :The New England journal of medicine 2009
Stefan K James Ulf Stenestrand Johan Lindbäck Jörg Carlsson Fredrik Scherstén Tage Nilsson Lars Wallentin Bo Lagerqvist

BACKGROUND The long-term safety and efficacy of drug-eluting coronary stents have been questioned. METHODS We evaluated 47,967 patients in Sweden who received a coronary stent and were entered into the Swedish Coronary Angiography and Angioplasty Registry between 2003 and 2006 and for whom complete follow-up data were available for 1 to 5 years (mean, 2.7). In the primary analysis, we compare...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید